Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trial

ConclusionAdding levosimendan to standard care in septic shock was not associated with less severe organ dysfunction nor lower mortality in patients with biochemical evidence of cardiac dysfunction.

http://link.springer.com/10.1007/s00134-019-05731-w

Source: Intensive Care Medicine - August 18, 2019 Category: Intensive Care Source Type: research